Is it feasible to use apps to support people with first episode psychosis?

Featured

In her debut blog, Rosa Pitts summarises the ARIES trial, which suggests it may be feasible to use a smartphone app (My Journey 3) to help prevent relapse in psychosis, although questions remain about long-term participant engagement with the app.

[read the full story...]

RESPECT! Find out what it means to me(ntal health services)

WhatsApp Image 2020-10-16 at 11.49.00

Beccy White explores the recently published RESPECT trial – a feasibility RCT which finds that a sexual health promotion intervention was safe and acceptable for people with severe mental illness.

[read the full story...]

Community navigators may help alleviate loneliness in people with anxiety or depression

Featured

Martin Webber summarises promising results from a feasibility trial of community navigators for people with depression or anxiety using secondary mental health services.

[read the full story...]

Reablement in a care home context: a feasibility study

REsize -claudia-van-zyl-652661-unsplash

Bruce McClure’s blog looks at a feasibility study of ‘LifeFul’, a reablement programme in the care home context.

[read the full story...]

Dementia in Down syndrome: Are we ready for a clinical trial?

down_syndrome_shutterstock_76649257-2

Leen Vereenooghe summarises the TOP-COG study (Towards Onset Prevention of COGnitive decline in adults with Down syndrome). This pilot RCT highlights the need to educate people with learning disabilities and their carers about the importance of research participation.

[read the full story...]

Is email good for your health?

7658165122_d832884270_k

Epica the Dog and her human friends from the Equator Publication School sniff out a novel study about the effectiveness of email-based exercises in promoting psychological wellbeing and healthy lifestyle.

[read the full story...]

Magic mushrooms promising for treatment resistant depression

Psilocybin

Our #EvidenceLive team of bloggers report on a recent feasibility study of psilocybin for the treatment of refractory depression.

[read the full story...]